DURECT Corp (DRRX) - Strategic SWOT Analysis Review

  • ID: 4225253
  • SWOT Analysis
  • 37 pages
  • GlobalData
  • Durect Corporation
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Knoll, Inc.
  • Medtronic Plc
  • Purdue Pharma LP
  • MORE
DURECT Corp (DRRX) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope:
  • Business Description - A detailed description of the company’s operations and business divisions.
  • Corporate Strategy - Our summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company History - Progression of key events associated with the company.
  • Major Products and Services - A list of major products, services and brands of the company.
  • Key Competitors - A list of key competitors to the company.
  • Key Employees - A list of the key executives of the company.
  • Executive Biographies - A brief summary of the executives’ employment history.
  • Key Operational Heads - A list of personnel heading key departments/functions.
  • Important Locations and Subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key Manufacturing Facilities - A list of key manufacturing facilities of the company.
Highlights

DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s major products include Alzet, an osmotic pump; and Lactel, a biodegradable polymer. The company’s product pipeline comprises DUR-928 indicated for treatment of acute organ injuries and metabolic/lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chronic pain and attention deficit hyperactivity disorder; and Relday, indicated for Schizophrenia and bipolar disorder. Durect’s major drug delivery technology platforms include Saber, Cloud, Oradur and Transdur. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in California, the US.

DURECT Corp Key Recent Developments

Mar 14,2017: DURECT Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs
Oct 31,2016: DURECT Announces Third Quarter 2016 Financial Results and Update of Programs
Aug 01,2016: DURECT Announces Second Quarter 2016 Financial Results and Update of Programs
May 05,2016: DURECT Announces First Quarter 2016 Financial Results and Update of Programs
Feb 29,2016: DURECT Announces Fourth Quarter 2015 Financial Results and Update of Programs

Reasons to Buy:

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Knoll, Inc.
  • Medtronic Plc
  • Purdue Pharma LP
  • MORE
Section 1 - About the Company
DURECT Corp - Key Facts
DURECT Corp - Key Employees
DURECT Corp - Key Employee Biographies
DURECT Corp - Major Products and Services
DURECT Corp - Medical Equipment Pipeline Products Data
DURECT Corp Pipeline Products by Equipment Type
DURECT Corp Pipeline Products by Development Stage
DURECT Corp - History
DURECT Corp - Company Statement
DURECT Corp - Locations And Subsidiaries
Head Office

Section 2 - Company Analysis
DURECT Corp - Business Description
DURECT Corp - Corporate Strategy
DURECT Corp - SWOT Analysis
SWOT Analysis - Overview
DURECT Corp - Strengths
DURECT Corp - Weaknesses
DURECT Corp - Opportunities
DURECT Corp - Threats
DURECT Corp - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
DURECT Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
DURECT Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
DURECT Corp, Recent Deals Summary

Section 4 - Company’s Recent Developments
Mar 14, 2017: DURECT Announces Fourth Quarter and Full Year 2016 Financial Results and Update of Programs
Oct 31, 2016: DURECT Announces Third Quarter 2016 Financial Results and Update of Programs
Aug 01, 2016: DURECT Announces Second Quarter 2016 Financial Results and Update of Programs
May 05, 2016: DURECT Announces First Quarter 2016 Financial Results and Update of Programs
Feb 29, 2016: DURECT Announces Fourth Quarter 2015 Financial Results and Update of Programs

Section 5 - Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables:
DURECT Corp, Key Facts
DURECT Corp, Key Employees
DURECT Corp, Key Employee Biographies
DURECT Corp, Major Products and Services
DURECT Corp Pipeline Products by Equipment Type
DURECT Corp Number of Pipeline Products by Development Stage
DURECT Corp Pipeline Products Summary by Development Stage
DURECT Corp, History
DURECT Corp, Key Competitors
DURECT Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
DURECT Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
DURECT Corp, Recent Deals Summary

List of Figures:
DURECT Corp Pipeline Products by Equipment Type
DURECT Corp Pipeline Products by Development Stage
DURECT Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
DURECT Corp, Medical Equipment, Deals by Type, 2011 to YTD
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Tricumed Medizintechnik GmbH
  • Purdue Pharma LP
  • Medtronic Plc
  • Knoll, Inc.
  • Immune Pharmaceuticals Inc
  • Cumberland Pharmaceuticals Inc
  • Avadel Pharmaceuticals Plc
  • AstraZeneca Plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll